Malignant growth of the tonsil is seen relatively infrequently by the great majority of physicians; yet it is of interest because (a) discovery of a case is provocative of a general review of this uncommon sarcoma; (b) the diagnosis and treatment of this neoplasm is established and followed very early in the course of this disease; (c) the statistical possibilities of cure are encouraging if one does happen to encounter this very uncommon growth. In the literature the statistics vary considerably on tonsillar cancer. Telch1 states that the five-year survival rate for all patients with tonsillar lymphosarcoma is 22%; with carcinoma, 5%. Ackerman and del Regato2 report 40% five-year cures in a group of 37 cases of lymphosarcoma of the tonsil. Parshall and Stenstrom3 report 6 (46%) survivals for three years among 13 patients and 3 (30%) among 10 for five years. This latter report was, of
FOSTVEDT LMR, FOSTVEDT GA. Lymphosarcoma of the Tonsil: A Case Report and a Brief Review. AMA Arch Otolaryngol. 1955;61(4):465–467. doi:10.1001/archotol.1955.00720020481013
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: